The research on safety of traditional Japanese herbal (Kampo) medicine, daiobotanpito in the treatment of acute diverticulitis: an intervention trial

The research on safety of traditional Japanese herbal (Kampo) medicine, daiobotanpito in the treatment of acute diverticulitis: an intervention trial - Safety of daiobotanpito in the treatment of acute diverticulitis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014808

Enrollment

Registered

2014-08-09

Start date

2014-08-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diverticulitis

Interventions

daiobotanpito use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with diverticulitis 2. Patients who have signed consent to participate in this research

Exclusion criteria

Exclusion criteria: 1. High probability to perforate. 2. Diarrhea or soft stool. 3. Chronic appetite loss, abdominal pain or diarrhea. 4. Too friable. 5. Insulin use. 6. Immuno-compromised host. 7. Pregnant or puerperal. 8. Kidney disease (eGFR < 20 ml/min/1.73m^2). 9. Allergy to daiobotampito. 10. Experience to jpin in this trial before. 11. No abdominal pain and fever. 12. Doctor's diagnosis as inappropriate.

Design outcomes

Primary

Measure	Time frame
Adverse events (type, frequency, and time of emergence)	—

Secondary

Measure	Time frame
Duration of abdominal pain Febrile period, and NSAID use CRP and WBC Size of abscess Frequency of defecation Aggravation daiobotampito use Antibiotics use Timing to resume meal	—

Countries

Japan

Contacts

Public ContactKoike, Hiroshi

Keio University School of Medicine Center for Kampo Medicine

koike-h@umin.ac.jp03-5366-3824

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026